Non-linear Optical Collagen Cross-linking (NLO CXL) for Treatment of Keratoconus
非线性光学胶原交联 (NLO CXL) 治疗圆锥角膜
基本信息
- 批准号:10611375
- 负责人:
- 金额:$ 39.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AreaBacterial InfectionsCell DeathCell SurvivalClinical ResearchCollagenCorneaCoupledDataDebridementDevicesDiameterDiffusionEpithelial CellsEpitheliumExcipientsExcisionEyeFundingGene ExpressionGoalsHourInflammationInflammatoryKeratoconusLasersLightMeasuresMinorModelingNerveOpticsOryctolagus cuniculusPainPathological DilatationPatientsPenetrationPhotonsPhysiologic pulsePlasmaPostoperative PainProceduresPublicationsRecoveryRefractive ErrorsResearchResearch Project GrantsRiboflavinRiskSafetyStromal CellsTestingTherapeuticUltraviolet RaysVisualadverse outcomecell injurycorneal epitheliumcorneal scarcrosslinkdensityexperienceindividual patientintraepithelialionizationlensnovelphotoactivationrepairedside effecttwo-photonwound healing
项目摘要
Project Summary/Abstract
Collagen crosslinking (CXL) using single photon, 380 nm, UVA light to photoactivate riboflavin (Rf) is
known to induce a two-fold increase in collagen stiffness and 1-3 diopters of corneal flattening. While these
effects have been shown to have significant therapeutic benefits for both treating Keratoconus and correcting
minor refractive errors, there are several major drawbacks to this procedure, including post-operative pain and
and delayed visual recovery with increased risk of bacterial infection and corneal scaring. In our recently
completed, NEI funded research project we developed a two-photon, nonlinear optical (NLO) CXL approach
using infrared femtosecond laser (FS) light that limits Rf photoactivation to the two-photon focal volume of an
objective lens. This device uses an amplified FS laser to generate 760 nm, 0.3 μJ pulses at less than 46.1
mW total power (under the ANSI thermal limit for laser eye exposure), and can crosslink a 4 mm diameter area
in less than 4 min, significantly enhance stromal stiffness 1.6 fold, and induce 1 to 2 diopters of corneal
flattening in live rabbits. As part of this project, we have also developed a novel, FS laser based, corneal
epithelial micromachining approach to create Microchannels (MicroCh) through the epithelium to greatly
enhance transepithelial (TE) Rf diffusion. Goal of this project is to test the hypothesis that post-operative pain
and delayed visual recovery is due to the excessive cellular damage caused by UVA CXL and that TE-NLO
CXL shows significantly less cell damage with faster visual recovery. This hypothesis will be tested through
the following specific aims: Aim 1. Optimize MicroCh TE Rf stromal penetration by determining the effects of
pulse energy, density and depth on Rf stromal concentration and epithelial/stromal integrity as compared to
other excipient TE approaches using ex vivo rabbit eyes. Aim 2. Determine the effects of TE Rf penetration
on corneal epithelial and stromal integrity comparing MicroCh to optimal excipient Rf approaches identified in
SA1 using an ex vivo rabbit eye model to measure epithelial/stromal cell death and induced inflammatory gene
expression at 3 hours and 24 hours with and without UVA or NLO CXL. Aim 3. Determine the effects MicroCh
Rf delivery and UVA versus NLO CXL in live rabbits by assessing the effects on epithelial integrity, corneal
sensitivity, stromal inflammation, wound healing and visual recovery.
项目总结/摘要
使用单光子、380 nm、UVA光来光活化核黄素(Rf)的胶原交联(CXL)是
已知其诱导胶原硬度增加两倍和角膜变平1-3屈光度。虽然这些
已经显示出对于治疗圆锥角膜和矫正圆锥角膜
虽然屈光不正较小,但该手术存在几个主要缺点,包括术后疼痛和
延迟视力恢复,增加细菌感染和角膜瘢痕形成的风险。在我们最近
完成,NEI资助的研究项目,我们开发了一种双光子,非线性光学(NLO)CXL方法
使用红外飞秒激光(FS)光,其将Rf光活化限制在
物镜透镜。该装置使用放大的FS激光器产生760 nm,0.3 μJ的脉冲,小于46.1
mW的总功率(低于ANSI对激光人眼照射的热限值),并且可以交联4 mm直径的区域
在小于4 min内,显著增强基质硬度1.6倍,并诱导1 - 2屈光度的角膜
在活兔子中变平。作为该项目的一部分,我们还开发了一种新型的基于FS激光的角膜
上皮微加工方法,以创建通过上皮的微通道(MicroCh),
增强跨上皮(TE)Rf扩散。这个项目的目标是测试手术后疼痛的假设,
延迟的视力恢复是由于UVA CXL引起的过度细胞损伤,
CXL显示出明显更少的细胞损伤,视力恢复更快。这一假设将通过
具体目标如下:目标1。通过确定以下因素的影响优化MicroCh TE Rf基质渗透
脉冲能量、密度和深度对Rf基质浓度和上皮/基质完整性的影响,
使用离体兔眼的其他赋形剂TE方法。目标2.确定TE Rf穿透的影响
对角膜上皮和基质完整性的影响,比较MicroCh与
SA 1使用离体兔眼模型测量上皮/基质细胞死亡和诱导的炎症基因
在有和没有UVA或NLO CXL的情况下,在3小时和24小时的表达。目标3。确定MicroCh的影响
通过评估对上皮完整性、角膜完整性和角膜完整性的影响,在活兔中比较Rf递送和UVA与NLO CXL
敏感性、基质炎症、伤口愈合和视力恢复。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Collagen fiber crimping following in vivo UVA-induced corneal crosslinking.
- DOI:10.1016/j.exer.2018.08.009
- 发表时间:2018-12
- 期刊:
- 影响因子:3.4
- 作者:Bradford SM;Mikula ER;Juhasz T;Brown DJ;Jester JV
- 通讯作者:Jester JV
Nonlinear optical corneal collagen crosslinking of ex vivo rabbit eyes.
- DOI:10.1016/j.jcrs.2016.06.040
- 发表时间:2016-11
- 期刊:
- 影响因子:2.8
- 作者:Bradford SM;Brown DJ;Juhasz T;Mikula E;Jester JV
- 通讯作者:Jester JV
Nonlinear optical crosslinking (NLO CXL) for correcting refractive errors.
- DOI:10.1016/j.exer.2020.108199
- 发表时间:2020-10
- 期刊:
- 影响因子:3.4
- 作者:Bradford S;Mikula E;Juhasz T;Brown DJ;Jester JV
- 通讯作者:Jester JV
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James V Jester其他文献
James V Jester的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James V Jester', 18)}}的其他基金
Non-linear Optical Collagen Cross-linking (NLO CXL) for Treatment of Keratoconus
非线性光学胶原交联 (NLO CXL) 治疗圆锥角膜
- 批准号:
10391522 - 财政年份:2014
- 资助金额:
$ 39.25万 - 项目类别:
Non-linear Optical Collagen Cross-linking (NLO CXL) for Treatment of Keratoconus
非线性光学胶原交联 (NLO CXL) 治疗圆锥角膜
- 批准号:
10222916 - 财政年份:2014
- 资助金额:
$ 39.25万 - 项目类别:
Non-linear Optical Collagen Cross-linking (NLO CXL) for Treatment of Keratoconus.
用于治疗圆锥角膜的非线性光学胶原交联 (NLO CXL)。
- 批准号:
8752184 - 财政年份:2014
- 资助金额:
$ 39.25万 - 项目类别:
Non-linear Optical Collagen Cross-linking (NLO CXL) for Treatment of Keratoconus.
用于治疗圆锥角膜的非线性光学胶原交联 (NLO CXL)。
- 批准号:
9303387 - 财政年份:2014
- 资助金额:
$ 39.25万 - 项目类别:
相似海外基金
New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
IFN诱导的OAS蛋白在针对细菌感染的先天免疫防御中的新作用
- 批准号:
10649771 - 财政年份:2023
- 资助金额:
$ 39.25万 - 项目类别:
Derivation and validation of a clinical prediction rule to identify febrile infants 61 to 90 days old at low and non-negligible risk of invasive bacterial infections
推导和验证临床预测规则,以识别 61 至 90 天大的发热婴儿,其侵袭性细菌感染的风险较低且不可忽略
- 批准号:
10574286 - 财政年份:2023
- 资助金额:
$ 39.25万 - 项目类别:
Structural and functional studies of YbtPQ for fighting bacterial infections
YbtPQ 对抗细菌感染的结构和功能研究
- 批准号:
10644889 - 财政年份:2023
- 资助金额:
$ 39.25万 - 项目类别:
A gut feeling: How can gastrointestinal bacterial infections alter female reproductive tract immunity and control of sexually transmitted infections
直觉:胃肠道细菌感染如何改变女性生殖道免疫力和性传播感染的控制
- 批准号:
MR/X031993/1 - 财政年份:2023
- 资助金额:
$ 39.25万 - 项目类别:
Research Grant
Molecular probes to diagnose pathoadapatations in bacterial infections
诊断细菌感染病理适应的分子探针
- 批准号:
EP/X014479/1 - 财政年份:2023
- 资助金额:
$ 39.25万 - 项目类别:
Research Grant
Using Small Area Variation Analysis to Investigate Sources of Practice Variation for Febrile Infants at Risk for Invasive Bacterial Infections
使用小面积变异分析来调查有侵袭性细菌感染风险的发热婴儿的实践变异来源
- 批准号:
10588846 - 财政年份:2023
- 资助金额:
$ 39.25万 - 项目类别:
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
- 批准号:
10674221 - 财政年份:2023
- 资助金额:
$ 39.25万 - 项目类别:
SimCell vaccines against Staphylococcus aureus bacterial infections
针对金黄色葡萄球菌细菌感染的 SimCell 疫苗
- 批准号:
10073241 - 财政年份:2023
- 资助金额:
$ 39.25万 - 项目类别:
Grant for R&D
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
- 批准号:
2306943 - 财政年份:2023
- 资助金额:
$ 39.25万 - 项目类别:
Standard Grant
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
- 批准号:
10549640 - 财政年份:2023
- 资助金额:
$ 39.25万 - 项目类别: